NCT01934478View on ClinicalTrials.gov

Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer

CompletedOBSERVATIONAL
Enrollment

5

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
Trial Locations (1)

266042

Qingdao Central Hospital, Qingdao Cancer Hospital, Qingdao

All Listed Sponsors
lead

Qingdao Central Hospital

OTHER

NCT01934478 - Radiotherapy Alternates Human Epidermal Growth Factor 2 (Her2) Expression in Human Breast Cancer | Biotech Hunter | Biotech Hunter